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| INTRODUC TI ON
Exosomes, small extracellular nanovesicles (30-100 nm) were first discovered few decades ago (Harding, Heuser, & Stahl, 1983; Pan & Johnstone, 1983) . Initially considered as a means of discarding cellular waste, exosomes were later found to play an important role in intercellular communications. Exosomes contain a variety of small molecules such as tetraspanins, cytokines, chemokines, lipids, mRNA and microRNA (Raposo & Stoorvogel, 2013; Turchinovich, Samatov, Tonevitsky, & Burwinkel, 2013; Vojtech et al., 2014) . Exosomes are encircled by a lipid bilayer, resulting from the inward budding of membrane of the late endosomal compartment. Generated when multivesicular bodies (of late endosomes) fuse with the plasma membrane, exosomes are then released from intraluminal vesicles into the extracellular compartment (Bobrie, Colombo, Raposo, & Thery, 2011; Harding et al., 1983; Simons & Raposo, 2009) . Once released in the extracellular compartment, exosomes can break down and release their content into that extracellular compartment or stay intact and interact with target cells by direct fusion with the plasma membrane (Ellwanger, Veit, & Chies, 2017) . They deliver their cargo to recipient cells and thereby modulate the host cell function, including innate immune response via the transfer of signalling molecules and antigens (Li et al., 2013; Schorey, Cheng, Singh, & Smith, 2015) . Through this mechanism, exosomes represent a new player in cell-to-cell communication pathways. In addition to cells, exosomes have been isolated from a variety of different bodily fluids, such as urine (Pisitkun, Shen, & Knepper, 2004) , saliva (Palanisamy et al., 2010) , blood (Caby, Lankar, Vincendeau-Scherrer, Raposo, & Bonnerot, 2005) , breast milk (Admyre et al., 2007) , vaginal fluids (Smith & Daniel, 2016) and semen (Madison, Roller, & Okeoma, 2014; Poliakov, Spilman, Dokland, Amling, & Mobley, 2009; Renneberg, Konrad, Dammshauser, Seitz, & Aumuller, 1997; Sullivan, Saez, Girouard, & Frenette, 2005; Vojtech et al., 2014) . Several methods of exosomes isolation have been investigated including serial steps of ultracentrifugation, polymer-based exosomal precipitation, bead-based immunologic method and nanotrap particles (Anderson, Kashanchi, & Jacobson, 2018) with each method presenting its advantages and drawbacks.
In this review, we will briefly summarise how exosomes derived from multiple biological matrices compared to seminal exosomes modulate HIV-1 infection, with a focus on regulation of immune responses.
| E XOSOME S AND HIV-1: CHAR AC TERIS TI C S AND IMPAC T
HIV-1 and exosomes are generally similar in their size (Gentile et al., 1994 ) and density range (Cimarelli & Luban, 2000) , making it difficult to purify exosomes from HIV-1 infected cells and fluids. Moreover, retroviruses such as HIV-1 and exosomes share common molecular properties in addition to morphological similarities (Cantin, Diou, Belanger, Tremblay, & Gilbert, 2008) . Both exosomes and retroviruses contain major histocompatibility complex class II (MHC-II) molecules, cell surface molecules such as integrins (CD11a, CD18), co-stimulatory molecules (CD28, CD54) and complement neutralising molecules (CD55, CD59). However, HIV-1 particles could be separated from exosomes by using an iodixanol (Optiprep™) velocity gradient as HIV-1 and exosomes sedimentation velocities are significantly different (Cantin et al., 2008) . Exosomes may impact retroviral infection based on biological similarities (Teow, Nordin, Ali, & Khoo, 2016) , either through HIV-1 originating in the same intracellular system as exosomes and using the exosome biogenesis pathway to assemble, disseminate and ultimately infect other cells, or via retroviruses hijacking the mechanism of intercellular communication, including exosomes, to spread and infect other cells. Several additional mechanisms by which exosomes can affect HIV-1 infection have also been proposed in a more recent review (Ellwanger et al., 2017) . HIV-1 can either release its viral proteins and RNA into exosomes or release virus particles surrounded by exosomes, or viral proteins can interfere with the exosomal release pathway. For example, Nef protein has been shown to reduce the expression of CD4 antigens in exosomes isolated from infected cells, in turn promoting HIV-1 replication (Arenaccio, Chiozzini, ColumbaCabezas, Manfredi, Affabris, et al., 2014; de Carvalho et al., 2014 While evidence supports that depending on the cellular source and the protocol of isolation/purification, exosomes can either stimulate or suppress immune responses (Hosseini, Fooladi, Nourani, & Ghanezadeh, 2013; Teow et al., 2016; Thery, Ostrowski, & Segura, 2009; Zhang & Grizzle, 2011) and facilitate or inhibit HIV-1 infection/ transmission (Table 1) , the exact role that exosomes play in HIV-1 infection has not been clearly elucidated. Furthermore, accumulating data suggest that exosomes may impact multiple stages of HIV-1 pathogenesis by modulating either target immune responses that alter infection, or by activating the latent viral reservoirs (Poveda & Freeman, 2017) .
| PL A S MA E XOSOME S AND HIV-1 INFEC TI ON
While the mechanisms underlying exosomal regulation of HIV-1 transmission are not known, it appears that exosomal morphology and function may be altered in HIV-1 infected individuals. Studies performed with plasma samples have shown that the content of cytokines and chemokines (Konadu et al., 2016) , as well as the quantity and size (Hubert et al., 2015) , of plasma exosomes from HIV-1-infected subjects were significantly higher compared with those of showing that short viral transcripts are still present in exosomes from patients with undetectable viral loads (Jaworski et al., 2014) .
ART regimens are able to suppress HIV-1 replication; nevertheless, low CD4 T-cell counts, immune activation and chronic inflammation can persist and are frequently associated with oxidative stress and elevated rates of comorbidities. Recently, it has been shown that monocytic cells treated with plasma exosomes derived from patients undergoing HAART induced expression of genes related to interferon responses and immune activation (Chettimada et al., 2018) .
These results suggest that plasma exosomes from patients using antiretrovirals may have pro-inflammatory effects promoting immune activation and oxidative stress and contributing to the chronic inflammation associated with HIV-1 disease progression and comorbidities even with suppressed viral loads. Other published data have shown that plasma exosomes enhance HIV-1 infection in human immune cell lines, with no indication on the patients' serology (Sims et al., 2017 (Sims et al., , 2018 . In contrast, plasma exosomes isolated from healthy, HIV-1-negative donors did not impact HIV-1 infection of monocytederived dendritic cells or HIV-1 transfer from those cells to CD4 + T cells (Naslund et al., 2014) . This suggests that exosomes derived from the same source (plasma) isolated from seronegative and in- 
| S EMINAL E XOSOME S AND HIV-1 INFEC TI ON

| Morphology and composition of seminal exosomes
Seminal plasma contains trillions of exosomes (Vojtech et al., 2014) . 
| Role in HIV-1 infection
Semen is known to have both immunostimulatory and immunosuppres- and measles virus infection (Kitamura et al., 1995) . entry into target cells (de Carvalho et al., 2014; Kadiu et al., 2012) .
Since there is considerable overlap in the cellular generation of enveloped viruses (including HIV-1) and exosomes (Gould, Booth, & Hildreth, 2003; , another hypothesis is that HIV-1 triggers alterations in SE composition and signalling.
These phenotypic changes may promote a cascade of functional effects, such as increased cytokine expression and target cell activation, with decreased DC maturation, which collectively compromise the induction of a protective immune response and promote HIV-1 infection in the female genital mucosa. SE isolated from the semen of healthy donors are generally immunosuppressive, inhibiting the activation of macrophages, NK cells and T cells (Kelly & Critchley, 1997; Kelly et al., 1991; Skibinski, Kelly, Harkiss, & James, 1992; Tarazona et al., 2011; Vojtech et al., 2014) . SE may therefore work in tandem with other components of semen, such as prostaglandins, to render the female reproductive tract less responsive to the presence of sperm antigens. This immune response favours conditions for fertilisation but could impact susceptibility to viral infection.
Exosomes from seronegative human semen have been shown to inhibit HIV-1 cellular entry and transmission in vitro. In TZM-bl cells, HIV-1 inhibition was more pronounced when SE were first preincubated with HIV-1 at 37°C, before exposure to the target cells (Madison et al., 2014) , showing a direct effect of SE on the virus.
Madison et al. showed that human vaginal epithelial cells V248 inter-
nalised SE by endocytosis and direct fusion with the cellular plasma membrane (Madison, Jones, & Okeoma, 2015) . Once internalised, SE are able to efficiently prevent transmission of HIV-1 infection from vaginal epithelial cells to CD4 + CCR5 + monocytic cells and CD4 + CXCR4 + T lymphocytes, as well as peripheral blood mononuclear cells . In vivo, SE can block intravaginal replication of murine AIDS (mAIDS) virus and limit the disease progression in mice . SE appear to inhibit HIV-1 replication post-virus entrance by disrupting reverse transcriptase (RT) activity, thereby impairing subsequent infectivity Madison et al., 2014) . Welch et al. recently showed that SE inhibit the binding of host transcription factors components such as NF-kB and SP1 to HIV-1 promoter and the interaction between Tat protein, involved in RT and gene expression, and those components (Welch, Kaddour, Schlievert, Stapleton, & Okeoma, 2018) . Although SE attenuate viral RT activity, viral replication in the presence of these exosomes possess the same amount of p24, but less viral RNA (Gag), than the viral progeny generated in the absence of SE. While SE are able to block HIV-1 and mAIDS virus complex infections, they have no effect on HSV types 1 and 2 replication (Madison et al., 2014) , suggesting that the antiviral activity of SE is restricted to HIV-1 or more generally to retroviruses. However, HSV, perhaps similarly to HIV-1, seems to hijack exosomes in different compartments modifying their composition and utilising them to disseminate to and infect other cells (Heikkila, Ryodi, & Hukkanen, 2016; Kalamvoki & Deschamps, 2016; Sadeghipour & Mathias, 2017) . The properties of SE isolated from HIV-1-infected patients have not been fully explored, and this represents a gap in the clear understanding of the role of exosomes in HIV-1 transmission.
| OTHER REPRODUC TIVE SYS TEM E XOSOME S AND HIV-1 INFEC TI ON
| Vaginal fluid exosomes
Similar to human semen, human vaginal fluid contains exosomes which have been found to reduce HIV-1 vector transmission by 60% in 293 T/17 cells (Smith & Daniel, 2016) . Integrated viral DNA and total viral DNA were both decreased by 47% and 58.4%, respectively, compared to the controls, in the presence of vaginal fluid exosomes (VFE). However, the efficiency of HIV-1 vector entry into target cells was not significantly different in the presence or absence of these exosomes (Smith & Daniel, 2016) . A similar decrease in HIV-1 transmission was also observed in Jurkat Clone E6-1 T cells in the presence of VFE by the same authors. The decrease in integration efficiency in presence of VFE could be due to the inhibitory effect of VFE on reverse transcription step. Because the HIV-1 vector used in those experiments has a different tropism and entry mechanism than HIV-1 virus, further research is needed to determine exactly the role of VFE in viral cervicovaginal infections by using the virus itself.
| Breast milk exosomes
Conflicting reports have been published on exosomes isolated from human breast milk from healthy donors. Indeed, pre-exposure to exosomes purified from human breast milk inhibits HIV-1 infection mediated by dendritic cells (DC) by binding to DC-SIGN, and blocking transport and transfer of virus to target CD4 + T cells (Naslund et al., 2014) . This might suggest that exosomes from milk may be protective against HIV-1 transmission from mother to child through breastfeeding. Two more recent papers (Sims et al., 2017 (Sims et al., , 2018 , however,
show that exosomes isolated from human breast milk can enhance HIV-1 entry when exosomes and HIV-1 are added at the same time to target cells (human CD4 + lymphoblastoid T and macrophage-like cell lines) and co-incubated for 3 days. These contradictory data may be the result of differences in exosome collection and purification or experimental design. This caveat also applies to many of the discrepant results reported on the functional role of exosomes.
The impact of SE, VFE, plasma, and breast milk exosomes on HIV-1 infection/transmission is summarised in Table 1 . . Immunology, 179(3), 1969 Immunology, 179(3), -1978 T lymphocytes to replicate HIV-1 through a Nef-and ADAM17-dependent mechanism. Journal of Virology, 88(19) , 11529-11539. https://doi.org/10.1128/jvi.01712-14 Arenaccio, C., Chiozzini, C., Columba-Cabezas, S., Manfredi, F., & Federico, M. (2014) . Cell activation and HIV-1 replication in unstimulated CD4 + T lymphocytes ingesting exosomes from cells
| RE S E ARCH PER S PEC TIVE S
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